Literature DB >> 30508591

Right ventricular involvement in hypertrophic cardiomyopathy: Patterns and implications.

Kalliopi Keramida1, George Lazaros2, Petros Nihoyannopoulos3.   

Abstract

Although hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy worldwide, the criteria for its definition and most of the literature concern the left ventricle, thus confirming the theory that the right ventricle is the neglected one. Right ventricular (RV) involvement includes structural and functional changes with significant impact on clinical presentation and prognosis. The pattern of RV hypertrophy can be variable with possible dynamic obstruction. Histological findings suggest similar pathogenetic changes in both ventricles supporting the common myopathic process with sarcomeric mutations. Systolic dysfunction of the RV is subtle, and the classical echocardiographic indices are usually within normal limits, while global longitudinal strain is significantly impaired. Diastolic dysfunction of the RV is also evident in patients with HCM possibly due to fibrosis of the RV free wall and/or the obstruction of the RV filling with significant prognostic implications. RV involvement in HCM is associated with increased incidence of supraventricular and ventricular arrhythmias, severe dyspnea, pulmonary thromboembolism, progressive heart failure, and increased risk of sudden cardiac death. Therefore, the RV should be routinely included in the detailed assessment of patients with HCM.
Copyright © 2018 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; Prognosis; Right ventricular involvement; Sudden cardiac death

Mesh:

Year:  2018        PMID: 30508591     DOI: 10.1016/j.hjc.2018.11.009

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  8 in total

1.  Isolated extreme right ventricular hypertrophy: A case report.

Authors:  Daiki Shako; Tatsuya Kawasaki; Michiyo Yamano; Satoaki Matoba
Journal:  J Cardiol Cases       Date:  2021-11-17

Review 2.  Evidence of Failed Resolution Mechanisms in Arrhythmogenic Inflammation, Fibrosis and Right Heart Disease.

Authors:  Rim Younes; Charles-Alexandre LeBlanc; Roddy Hiram
Journal:  Biomolecules       Date:  2022-05-19

3.  Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.

Authors:  Masliza Mahmod; Betty Raman; Hugh Watkins; Stefan Neubauer; Kenneth Chan; Sanjay Sivalokanathan; Robert W Smillie; Azlan H Abd Samat; Rina Ariga; Sairia Dass; Elizabeth Ormondroyd
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-13       Impact factor: 6.903

4.  Cardiac Magnetic Resonance with Delayed Enhancement of the Right Ventricle in patients with Left Ventricle primary involvement: diagnosis and evaluation of functional parameters.

Authors:  Patrizia Toia; Erica Maffei; Cesare Mantini; Giuseppe Runza; Ludovico La Grutta; Emanuele Grassedonio; Andrea Guaricci; Bruna Punzo; Carlo Cavaliere; Filippo Cademartiri
Journal:  Acta Biomed       Date:  2022-05-11

5.  Severe right ventricular hypertrophy in hypertrophic cardiomyopathy: Serious symptoms, complex surgical procedures, and poor prognosis in Fuwai Hospital.

Authors:  Xueqi Dong; Di Zhang; Yi Qu; Xu Meng; Lin Zhao; Xianliang Zhou; Yaxin Liu
Journal:  Anatol J Cardiol       Date:  2021-07       Impact factor: 1.596

6.  Diabetes mellitus: Lessons from the COVID-19 pandemic.

Authors:  Dimitris Tousoulis
Journal:  Hellenic J Cardiol       Date:  2020-05-18

7.  Patterns of Left Ventricular Hypertrophy and Late Gadolinium Enhancement on Cardiac MRI in Patients with Hypertrophic Cardiomyopathy and their Prognostic Significance - An Experience from a South Asian Country.

Authors:  Fateh Ali Tipoo Sultan; Sheema Saadia
Journal:  J Clin Imaging Sci       Date:  2021-03-04

8.  Predictors of right ventricular function and size in patients with hypertrophic cardiomyopathy.

Authors:  Mateusz Śpiewak; Mariusz Kłopotowski; Łukasz Mazurkiewicz; Ewa Kowalik; Joanna Petryka-Mazurkiewicz; Barbara Miłosz-Wieczorek; Anna Klisiewicz; Adam Witkowski; Magdalena Marczak
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.